These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25834302)

  • 1. Rebamipide protects small intestinal mucosal injuries caused by indomethacin by modulating intestinal microbiota and the gene expression in intestinal mucosa in a rat model.
    Kurata S; Nakashima T; Osaki T; Uematsu N; Shibamori M; Sakurai K; Kamiya S
    J Clin Biochem Nutr; 2015 Jan; 56(1):20-7. PubMed ID: 25834302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebamipide ameliorates indomethacin-induced small intestinal injury in rats via the inhibition of matrix metalloproteinases activity.
    Yamada S; Naito Y; Takagi T; Mizushima K; Horie R; Fukumoto K; Inoue K; Harusato A; Uchiyama K; Handa O; Yagi N; Ichikawa H; Yoshikawa T
    J Gastroenterol Hepatol; 2012 Dec; 27(12):1816-24. PubMed ID: 23020299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebamipide inhibits indomethacin-induced small intestinal injury: possible involvement of intestinal microbiota modulation by upregulation of α-defensin 5.
    Tanigawa T; Watanabe T; Otani K; Nadatani Y; Ohkawa F; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
    Eur J Pharmacol; 2013 Mar; 704(1-3):64-9. PubMed ID: 23428631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rebamipide ameliorates indomethacin-induced small intestinal damage and proton pump inhibitor-induced exacerbation of this damage by modulation of small intestinal microbiota.
    Tanigawa T; Watanabe T; Higashimori A; Shimada S; Kitamura H; Kuzumoto T; Nadatani Y; Otani K; Fukunaga S; Hosomi S; Tanaka F; Kamata N; Nagami Y; Taira K; Shiba M; Suda W; Hattori M; Fujiwara Y
    PLoS One; 2021; 16(1):e0245995. PubMed ID: 33507971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rebamipide, a gastro-protective drug, inhibits indomethacin-induced apoptosis in cultured rat gastric mucosal cells: association with the inhibition of growth arrest and DNA damage-induced 45 alpha expression.
    Naito Y; Kajikawa H; Mizushima K; Shimozawa M; Kuroda M; Katada K; Takagi T; Handa O; Kokura S; Ichikawa H; Yoshida N; Matsui H; Yoshikawa T
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S104-12. PubMed ID: 16184411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of rebamipide on indomethacin-induced intestinal damage in rats.
    Mizoguchi H; Ogawa Y; Kanatsu K; Tanaka A; Kato S; Takeuchi K
    J Gastroenterol Hepatol; 2001 Oct; 16(10):1112-9. PubMed ID: 11686837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebamipide Promotes the Regeneration of Aspirin-Induced Small-Intestine Mucosal Injury through Accumulation of β-Catenin.
    Lai Y; Zhong W; Yu T; Xia ZS; Li JY; Ouyang H; Shan TD; Yang HS; Chen QK
    PLoS One; 2015; 10(7):e0132031. PubMed ID: 26135128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome Analysis for Cytoprotective Actions of Rebamipide against Indomethacin-Induced Gastric Mucosal Injury in Rats.
    Naito Y; Kuroda M; Mizushima K; Takagi T; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
    J Clin Biochem Nutr; 2007 Nov; 41(3):202-10. PubMed ID: 18299717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rebamipide reduces indomethacin-induced gastric injury in mice via down-regulation of ICAM-1 expression.
    Hiratsuka T; Futagami S; Shindo T; Hamamoto T; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Shinoki K; Wada K; Miyake K; Gudis K; Tsukui T; Sakamoto C
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S84-9. PubMed ID: 16184426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rebamipide, a mucoprotective drug, inhibits NSAIDs-induced gastric mucosal injury: possible involvement of the downregulation of 15-hydroxyprostaglandin dehydrogenase.
    Tanigawa T; Watanabe T; Ohkawa F; Nadatani Y; Otani K; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
    J Clin Biochem Nutr; 2011 Mar; 48(2):149-53. PubMed ID: 21373268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study.
    Naito Y; Yoshikawa T; Iinuma S; Yagi N; Matsuyama K; Boku Y; Fujii T; Yoshida N; Kondo M; Sasaki E
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):83S-89S. PubMed ID: 9753232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rebamipide significantly inhibits indomethacin-induced mitochondrial damage, lipid peroxidation, and apoptosis in gastric epithelial RGM-1 cells.
    Nagano Y; Matsui H; Muramatsu M; Shimokawa O; Shibahara T; Yanaka A; Nakahara A; Matsuzaki Y; Tanaka N; Nakamura Y
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S76-83. PubMed ID: 16184425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terminal-restriction fragment length polymorphism (T-RFLP) analysis for changes in the gut microbiota profiles of indomethacin- and rebamipide-treated mice.
    Imaeda H; Fujimoto T; Takahashi K; Kasumi E; Fujiyama Y; Andoh A
    Digestion; 2012; 86(3):250-7. PubMed ID: 22964750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Involvement of endogenous tachykinins in the development of jejunal mucosa injury induced by on-steroidal anti-inflammatory drugs].
    Sendur P; Ceranowicz P; Sendur R; Cieszkowski J; Warzecha Z; Dembiński A
    Przegl Lek; 2013; 70(2):48-52. PubMed ID: 23879003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophils in rats.
    Murakami K; Okajima K; Harada N; Isobe H; Okabe H
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):139S-142S. PubMed ID: 9753240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of indomethacin on the rat small intestinal mucosa: immunohistochemical and biochemical studies using anti-mucin monoclonal antibodies.
    Iwai T; Ichikawa T; Goso Y; Ikezawa T; Saegusa Y; Okayasu I; Saigenji K; Ishihara K
    J Gastroenterol; 2009; 44(4):277-84. PubMed ID: 19280111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional mechanism underlying cyclooxygenase-2 expression in rat small intestine following administration of indomethacin: relation to intestinal hypermotility.
    Tanaka A; Matsumoto M; Hayashi Y; Takeuchi K
    J Gastroenterol Hepatol; 2005 Jan; 20(1):38-45. PubMed ID: 15610444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Bach1 ameliorates indomethacin-induced intestinal injury in mice.
    Harusato A; Naito Y; Takagi T; Yamada S; Mizushima K; Hirai Y; Horie R; Inoue K; Fukumoto K; Hirata I; Omatsu T; Kishimoto E; Uchiyama K; Handa O; Ishikawa T; Kokura S; Ichikawa H; Muto A; Igarashi K; Yoshikawa T
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():149-54. PubMed ID: 20388958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1.
    Yoda Y; Amagase K; Kato S; Tokioka S; Murano M; Kakimoto K; Nishio H; Umegaki E; Takeuchi K; Higuchi K
    J Physiol Pharmacol; 2010 Jun; 61(3):287-94. PubMed ID: 20610858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemopexin is upregulated in rat intestinal mucosa injured by indomethacin.
    Takagi T; Naito Y; Okada H; Takaoka M; Oya-Ito T; Yamada S; Hirai Y; Mizushima K; Yoshida N; Kamada K; Katada K; Uchiyama K; Ishikawa T; Handa O; Yagi N; Konishi H; Kokura S; Ichikawa H; Yoshikawa T
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():70-5. PubMed ID: 22486875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.